Elsevier

JACC: Cardiovascular Imaging

Volume 14, Issue 12, December 2021, Pages 2457-2469
JACC: Cardiovascular Imaging

State-of-the-Art Review
Multimodality Imaging Assessment of Myocardial Fibrosis

https://doi.org/10.1016/j.jcmg.2021.01.027Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Myocardial fibrosis can manifest as focal replacement or diffuse interstitial fibrosis.

  • Multimodality imaging of myocardial fibrosis can be direct or indirect and includes use of cardiac magnetic resonance, computed tomography, and nuclear imaging.

  • Understanding the roles and limitations of each imaging modality is critical for test selection.

Abstract

Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and quantification of myocardial fibrosis with the use of an expanding array of techniques including cardiac magnetic resonance, computed tomography, and nuclear imaging. This review discusses currently available noninvasive imaging techniques, provides insights into their strengths and limitations, and examines novel developments that will affect the future of noninvasive imaging of myocardial fibrosis.

Key Words

cardiac computed tomography
cardiac magnetic resonance
late gadolinium enhancement
myocardial fibrosis
nuclear imaging
T1 mapping

Abbreviations and Acronyms

CMR
cardiac magnetic resonance
CT
computed tomography
CT-DE
computed tomographic delayed enhancement
DCM
dilated cardiomyopathy
ECM
extracellular matrix
ECV
extracellular volume
HCM
hypertrophic cardiomyopathy
IR
inversion recovery
LGE
late gadolinium enhancement
LL
Look-Locker
LV
left ventricular
MI
myocardial infarction
MOLLI
modified Look-Locker imaging
PET
positron-emission tomography
PSIR
phase-sensitive inversion recovery
PTI
perfusable tissue index
SPECT
single photon-emission computed tomography
SR
saturation recovery
T-CRIP
99mTc-labeled cyanine-5.5 Arg-Gly-Asp imaging peptide

Cited by (0)

Erik Schelbert, MD, served as Guest Editor for this paper.

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.

Drs. Gupta and Ge contributed equally to this work and are joint first authors.